TCL1A in naïve B cells as a therapeutic target for type 1 diabetesResearch in context

TCL1A in naïve B cells as a therapeutic target for type 1 diabetesResearch in context

Summary: Background: Type 1 diabetes (T1D) is an autoimmune disease characterised by the attack of pancreatic β cells by “self” immune cells. Although previous studies demonstrated that B cells contribute to T1D through antigen presentation and autoantibody production, the involvement of different...

Celý popis

Podrobná bibliografie
Hlavní autoři: Siweier Luo, Lina Zhang, Chunfang Wei, Chipeng Guo, Zhe Meng, Honghui Zeng, Lele Hou, Le Wang, Zulin Liu, Yufei Du, Shiyu Tan, Yating Zhang, Xiaoding Xu, Liyang Liang, Yiming Zhou
Médium: Článek
Jazyk:English
Vydáno: Elsevier 2025-03-01
Edice:EBioMedicine
Témata:
Type 1 diabetes
Single-cell RNA-sequencing
B cell
TCL1
AKT signalling
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2352396425000374

Internet

http://www.sciencedirect.com/science/article/pii/S2352396425000374

Podobné jednotky